Personal Care Related News

From BIOtech to bioTECH: Meet Serial Entrepreneur Randal Kirk, CEO of Intrexon

There will be a lot of synthetic biologists at the upcoming conference, and a lot of entrepreneurs hoping to scale their company to greatness and riches (often these two are combined into the same person). It is, however, a difficult [...]

Intrexon Stock Offering Generates $230 Million

The synthetic biology company Intrexon Corporation recently announced the closing of its public stock offering, which garnered $230 million dollars from the sale of more than 5.5 million shares in the course of a week. This is just the latest [...]

3 Potential New Molecules for Amyris’ Portfolio in 2014

Synthetic biology pioneer Amyris may have spent much of last year slashing wasteful spending and reevaluating its strategic vision, but it also achieved several major farnesene production milestones at its lone commercial facility in Brotas, Brazil. While the company will continue to [...]